Subject: | |
From: | |
Reply To: | |
Date: | Sun, 25 Nov 2007 19:52:16 -0600 |
Content-Type: | text/plain |
Parts/Attachments: |
|
|
There is an interesting article in today's NY Times Magazine
(November 25, 2007, page 64) called "Dr. Drug Rep" by Daniel Carlat.
It has implications for how we look at the formula companies and the
ways they manage to influence health care workers. Dr. Carlat
initially felt honored to be invited to give educational talks to
other physicians about a specific drug. After a year he quit
($30,000 richer), troubled by the ethical questions of what he was
doing. He describes how he came to downplay worrisome side effects
and overstate benefits of the drug and all the subtle ways he was
persuaded to do this. There is lots of information about how the
drug companies track physicians' prescription patterns, work to
ingratiate and befriend health care workers, wine and dine them, etc.
The article is also on line at http://www.nytimes.com/2007/11/25/
magazine/25memoir-t.html?em&ex=1196139600&en=15660360f7d60ac9&ei=5070
Anne Altshuler, RN, MS, IBCLC
***********************************************
Archives: http://community.lsoft.com/archives/LACTNET.html
To reach list owners: [log in to unmask]
Mail all list management commands to: [log in to unmask]
COMMANDS:
1. To temporarily stop your subscription write in the body of an email: set lactnet nomail
2. To start it again: set lactnet mail
3. To unsubscribe: unsubscribe lactnet
4. To get a comprehensive list of rules and directions: get lactnet welcome
|
|
|